Prion protein conversions: Insight into mechanisms, TSE transmission barriers and strains

British Medical Bulletin

Volumn 66, Issue , 2003, Pages 109-120

  Caughey, Byron ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN; PROTEINASE;

BIOTRANSFORMATION; DIAGNOSTIC TEST; DISEASE TRANSMISSION; PATHOGENESIS; PRION DISEASE; PRIORITY JOURNAL; REVIEW; STRAIN IDENTIFICATION;

ANIMALS; CATTLE; CELL MEMBRANE; DISEASE SUSCEPTIBILITY; ENCEPHALOPATHY, BOVINE SPONGIFORM; ENDOPEPTIDASES; HUMANS; POLYMERS; PRIONS; PROTEIN BINDING; PRPSC PROTEINS;

EID: 0141849856     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/bmb/66.1.109     Document Type: Review

References (64)

1. Caughey B, Raymond GJ. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 1991; 266: 18217-23
2. Harris DA. Biosynthesis and cellular processing of the prion protein. Adv Protein Chem 2001; 57: 203-28
3. Alonso D, Daggett V. Simulations and computational analyses of prion protein conformations. Adv Protein Chem 2001; 57: 107-37
4. Glockshuber R. Folding dynamics and energetics of recombinant prion proteins. Adv Protein Chem 2001; 57: 83-105
5. DebBurman SK, Raymond GJ, Caughey B, Lindquist S. Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci USA 1997; 94: 13938-43
6. Horiuchi M, Chabry J, Caughey B. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J 1999; 18: 3193-203
7. Horiuchi M, Priola SA, Chabry J, Caughey B. Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers. Proc Natl Acad Sci USA 2000; 97: 5836-41
8. Kocisko DA, Come JH, Priola SA et al. Cell-free formation of protease-resistant prion protein. Nature 1994; 370: 471-4
9. Sc dependent cell-free formation of protease-resistant prion protein. EMBO J 2001; 20: 377-86
10. Baron GS, Wehrly K, Dorward DW, Chesebro B, Caughey B. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO J 2002; 21: 1031-40
11. Sc formation in neuroblastoma cells infected with different prion strains. J Gen Virol 2000; 81: 2555-63
12. Vorberg I, Priola SA. Molecular basis of scrapie strain glycoform variation. J Biol Chem 2002; 277: 36775-81
13. Bessen RA, Raymond GJ, Caughey B. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices. J Biol Chem 1997; 272: 15227-31
14. Saborio GP, Soto C, Kascsak RJ et al. Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone. Biochem Biophys Res Commun 1999; 258: 470-5
15. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411: 810-3
16. Scott MR, Kohler R, Foster D, Prusiner SB. Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci 1992; 1: 986-97
17. Hill AF, Antoniou M, Collinge J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol 1999; 80: 11-4
18. Caughey B, Raymond GJ, Kocisko DA, Lansbury Jr PT. Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies. J Virol 1997; 71: 4107-10
19. Priola SA. Prion protein diversity and disease in the transmissible spongiform encephalopathies. Adv Protein Chem 2001; 57: 1-27
20. Asante EA, Collinge J. Transgenic studies of the influence of the PrP structure on TSE diseases. Adv Protein Chem 2001; 57: 273-311
21. Caughey B, Raymond GJ, Callahan MA, Wong C, Baron GS, Xiong L. Interactions and conversions of prion protein isoforms. Adv Protein Chem 2001; 57: 139-69
22. Raymond GJ, Bossers A, Raymond LD et al. Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease. EMBO J 2000; 19: 4425-30
23. Raymond GJ, Hope J, Kocisko DA et al. Molecular assessment of the transmissibilities of BSE and scrapie to humans. Nature 1997; 388: 285-8
24. Bossers A, de Vries R, Smits MA. Susceptibility of sheep for scrapie as assessed by in vitro conversion of nine naturally occurring variants of PrP. J Virol 2000; 74: 1407-14
25. Miller MW, Williams ES, McCarty CW et al. Epidemiology of chronic wasting disease in free-ranging cervids. J Wildl Dis 2000; 36: 676-90
26. Bartz JC, Marsh RF, McKenzie DI, Aiken JM. The host range of chronic wasting disease is altered on passage in ferrets. Virology 1998; 251: 297-301
27. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95: 13363-83
28. Priola SA. Prion protein and species barriers in the transmissible spongiform encephalopathies. Biomed Pharmacother 1999; 53: 27-33
29. Horiuchi M, Caughey B. Prion protein interconversions and the transmissible spongiform encephalopathies. Structure Fold Des 1999; 7: R231-40
30. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury Jr PT, Caughey B. Non-genetic propagation of strain-specific phenotypes of scrapie prion protein. Nature 1995; 375: 698-700
31. Wadsworth JD, Hill AF, Joiner S, Jackson GS, Clarke AR, Collinge J. Strain-specific prion-protein conformation determined by metal ions [see comments]. Nat Cell Biol 1999; 1: 55-9
32. Bruce ME, McBride PA, Farquhar CF. Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie. Neurosci Lett 1989; 102: 1-6
33. Caughey B. Cellular metabolism of normal and scrapie-associated forms of PrP. Semin Virol 1991; 2: 189-96
34. Caughey B, Kocisko DA, Raymond GJ, Lansbury PT. Aggregates of scrapie associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem Biol 1995; 2: 807-17
35. Callahan MA, Xiong L, Caughey B. Reversibility of scrapie-associated prion protein aggregation. J Biol Chem 2001; 276: 28022-8
36. Morrissey MP, Shakhnovich EI. Evidence for the role of PrP(C) helix 1 in the hydrophilic seeding of prion aggregates. Proc Natl Acad Sci USA 1999; 96: 11293-8
37. Speare JO, Rush TS, Bloom ME, Caughey B. The role of helix 1 aspartates and salt bridges in the stability and conversion of prion protein. J Biol Chem 2003; 278: 12522-9
38. Welker E, Wedemeyer WJ, Scheraga HA. A role for intermolecular disulfide bonds in prion diseases? Proc Natl Acad Sci USA 2001; 98: 4334-6
39. Knaus KJ, Morillas M, Swietnicki W, Malone M, Surewicz WK, Yee VC. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol 2001; 8: 770-4
40. Welker E, Raymond LD, Scheraga HA, Caughey B. Intramolecular versus intermolecular disulfide bonds in prion proteins. J Biol Chem 2002; 277: 33477-81
41. Wickner RB, Taylor KL, Edskes HK, Maddelein ML, Moriyama H, Roberts BT. Yeast prions act as genes composed of self-propagating protein amyloids. Adv Protein Chem 2001; 57: 313-34
42. Serio TR, Lindquist SL. The yeast prion [PSI+]: molecular insights and functional consequences. Adv Protein Chem 2001; 59: 391-412
43. Jarrett JT, Lansbury Jr PT. Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993; 73: 1055-8
44. Lansbury Jr PT, Caughey B. The chemistry of scrapie infection: implications of the 'ice 9' metaphor. Chem Biol 1995; 2: 1-5
45. Caughey B. Interactions between prion protein isoforms: the kiss of death? Trends Biochem Sci 2001; 26: 235-42
46. Wille H, Michelitsch MD, Guenebaut V et al. Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci USA 2002; 99: 3563-8
47. Horiuchi M, Baron GS, Xiong LW, Caughey B. Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain. J Biol Chem 2001; 276: 15489-97
48. Brimacombe DB, Bennett AD, Wusteman FS, Gill AC, Dann JC, Bostock CJ. Characterization and polyanion-binding properties of purified recombinant prion protein. Biochem J 1999; 342: 605-13
49. Graner E, Mercadante AF, Zanata SM et al. Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res Mol Brain Res 2000; 76: 85-92
50. Gauczynski S, Hundt C, Leucht C, Weiss S. Interaction of prion proteins with cell surface receptors, molecular chaperones and other molecules. Adv Protein Chem 2001; 57: 229-72
51. Caughey B, Raymond GJ. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol 1993; 67: 643-50
52. Caughey B, Race RE. Potent inhibition of scrapie-associated PrP accumulation by Congo Red. J Neurochem 1992; 59: 768-71
53. Caughey B, Ernst D, Race RE. Congo Red inhibition of scrapie agent replication. J Virol 1993; 67: 6270-2
54. Caughey WS, Raymond LD, Horiuchi M, Caughey B. Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proc Natl Acad Sci USA 1998; 95: 12117-22
55. Demaimay R, Harper J, Gordon H, Weaver D, Chesebro B, Caughey B. Structural aspects of Congo Red as an inhibitor of protease-resistant prion protein formation. J Neurochem 1998; 71: 2534-41
56. Rudyk H, Vasiljevic S, Hennion RM, Birkett CR, Hope J, Gilbert IH. Screening Congo Red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells. J Gen Virol 2000; 81: 1155-64
57. Chabry J, Caughey B, Chesebro B. Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. J Biol Chem 1998; 273: 13203-7
58. Chabry J, Priola SA, Wehrly K, Nishio J, Hope J, Chesebro B. Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence. J Virol 1999; 73: 6245-50
59. Doh-ura K, Iwaki T, Caughey B. Lysosomotropic agents and cysteine protease inhibitors inhibit accumulation of scrapie-associated prion protein. J Virol 2000; 74: 4894-7
60. Supattapone S, Nguyen HO, Cohen FE, Prusiner SB, Scott MR. Elimination of prions by branched polyamines and implications for therapeutics. Proc Natl Acad Sci USA 1999; 96: 14529-34
61. Sc in scrapie-infected mouse neuroblastoma cells. Biol Chem 2000; 381: 463-9
62. Perrier V, Wallace AC, Kaneko K, Safar J, Prusiner SB, Cohen FE. Mimicking dominant negative inhibition of prion replication through structure-based drug design. Proc Natl Acad Sci USA 2000; 97: 6073-8
63. Winklhofer KF, Hartl FU, Tatzelt J. A sensitive filter retention assay for the detection of PrP(Sc) and the screening of anti-prion compounds. FEBS Lett 2001; 503: 41-5
64. Baron GS, Caughey B. Effect of glycophosphatidyl inositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoform. J Biol Chem 2003; 278: 14883-92